SCHEMBL31663595

SCHEMBL31663595

N#Cc1cc(-c2ccccc2)c(-c2ccccc2)c(-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.54
MAPK1 P28482 1/20 0.54
ADORA1 P30542 5/20 0.50
ADORA2A P29274 4/20 0.50
MYC P01106 1/20 0.48
SQOR Q9Y6N5 3/20 0.48
KDM4E B2RXH2 4/20 0.47
HPGD P15428 4/20 0.47
NPSR1 Q6W5P4 3/20 0.47
PPARG P37231 1/20 0.47
NCOA2 Q15596 1/20 0.47
NCOA1 Q15788 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
METAP2 P50579 1/20 0.46
LMNA P02545 3/20 0.44
KMT2A Q03164 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31663525 0.86 ABCG2 (0.50) L3MBTL1MAPK1ADORA1ADORA2ASQOR
SCHEMBL7213476 0.86 MYC (0.54) L3MBTL1MAPK1ADORA1ADORA2AMYC
SCHEMBL20740870 0.86 METAP2 (0.51) L3MBTL1MAPK1ADORA1ADORA2AHPGD
SCHEMBL31663512 0.79 ADORA1 (0.49) L3MBTL1MAPK1ADORA1ADORA2AMYC
SCHEMBL23841676 0.79 MYC (0.56) L3MBTL1MAPK1ADORA1ADORA2AMYC
SCHEMBL31663588 0.78 TGFBR1 (0.45) L3MBTL1MAPK1SQORKDM4EHPGD
SCHEMBL22987168 0.75 MYC (0.63) L3MBTL1MAPK1ADORA1ADORA2AMYC
SCHEMBL22987245 0.75 MYC (0.63) L3MBTL1MAPK1ADORA1ADORA2AMYC
SCHEMBL22987251 0.75 MYC (0.63) L3MBTL1MAPK1ADORA1ADORA2AMYC
SCHEMBL22987035 0.75 MYC (0.63) L3MBTL1MAPK1ADORA1ADORA2AMYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 L3MBTL1 1198/4885MAPK1 4873/4885ADORA1 3690/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 L3MBTL1 1198/4885MAPK1 4873/4885ADORA1 3690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.